'I'd rather be fat and clearheaded...';'Lieber dick und geistig da...'

Psychiatrische Praxis

Volumn 26, Issue 4, 1999, Pages 188-193

  Boitz, Katrin ^b   Angermeyer, Matthias C ^a   Löffler, Walter ^b   Müller, Peter ^b   Priebe, Stefan ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

ARTICLE; DRUG EFFECT; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; SCHIZOPHRENIA; SOMNOLENCE; ADOLESCENT; ADULT; ATTITUDE TO HEALTH; FEMALE; HOSPITAL DISCHARGE; MALE; MIDDLE AGED; PATIENT EDUCATION; PSYCHOLOGY; RISK FACTOR; TREATMENT OUTCOME; WEIGHT GAIN;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; ATTITUDE TO HEALTH; CLOZAPINE; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT DISCHARGE; PATIENT EDUCATION; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 0033159462     PISSN: 03034259     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Angermeyer MC. Compliance schizophrener Kranker mit Neuroleptika-Medikation In: Möller, H-J (Hrsg.): Langzeiterfahrungen mit Glianimon. Köln: Tropon, 1990: 163-177
2. Angermeyer MC, Matschinger H. Neuroleptika und Lebensqualität: Ergebnisse einer Patientenbefragung. Psychiat. Prax. 1999; 26: (im Druck)
3. Day JC, Bentall RP, Wagner S. Schizophrenic patients' experiences of neuroleptic medication: a Q-methodologic investigation. Acta Psychiatr. Scand. 1996; 93: 397-402
4. Finn M, Bailey JM, Schultz RT, Faber R. Subjective utility ratings of neuroleptics in treating schizophrenia. Psychol. Med. 1990; 35: 843-848
5. Küchenhoff B. Die wichtigsten Nebenwirkungen unter Clozapin (Leponex) und ihre Behandlung. Psychiat. Prax. 1993; 20: 201-206
6. Lamnek S. Qualitative Sozialforschung. Band 2 Methoden und Techniken. München: Verlags Union, 1989
7. Mayring P. Qualitative Inhaltsanalyse. Weinheim: Deutscher Studienverlag, 1990
8. Naber D. A self rating to measure subjective effects of neuroleptic drugs, relationship to objective psychopathology, quality of life, compliance and other clinical variables. Int. Clin. Psychopharmacology 1995; 10 (Suppl. 3): 133-138
9. Naber D, Holzbach R, Perro C, Hippius H. Clinical management of Clozapine patients in relation to efficacy and side-effects. Br. J. Psychiatry 1992; 160 (Suppl. 17): 54-59
10. Retzow A, Emrich HM. Therapie bipolarer affektiver Erkrankungen mit Valproat. Psychiat. Prax. 1998; 25: 163-171
11. Windgassen K. Schizophreniebehandlung aus der Sicht der Patienten. Berlin, Heidelberg, New York: Springer, 1989